sales@scalarmarketresearch.com  |   +1-800-213-5170  (U.S./ Canada Toll-free)  |  REGISTER |  SIGN IN

Home >> Reports >> antibodies market

report

Antibodies Market, by Technology (Monoclonal Antibodies, Polyclonal Antibodies, Antibody Drug Conjugate), Disease Indications (Cardiovascular Diseases, CNS Disorders, Cancer, Autoimmune Disorders), End-users (Hospitals, Long Term Care Facilities, Research institutes) - Global Revenue, Trends, Growth, Share, Size and Forecast to 2022

HC212 January 2017 100+ FREE 10% CUSTOMIZATION

The objective of this report is to describe the market trends and revenue forecasts for the antibodies market for the next five years. The report focuses on defining and describing the key influencing factors for the growth of the market. It also offers an in-depth analysis of the market size (revenue), market share, major market segments, different geographic regions, key market players, and premium industry trends.

The report tracks the major market events including product launches, technological developments, mergers & acquisitions, and the innovative business strategies opted by key market players. Along with strategically analyzing the key micro markets, the report also focuses on industry-specific drivers, restraints, opportunities and challenges in the antibodies market.The scope of this report covers the antibodies market by its major segments, which include the type, disease indications, end-users and the major geographic regions.

KEY BENEFITS OF THE REPORT:

  • In-depth analysis of the market segments that will showcase the greatest growth potential
  • Deeper understanding of the behavior of the key players and innovators influencing this market
  • Granular understanding of the historical market trend and the resultant market forecast
  • Information about the technological advancements influencing the growth of the global market
  • Extensive evaluation of all the market dynamics that will impact this market during the forecast period
  • Understanding of the strategies that are being adopted by the key players in this market to stay competitive

RESEARCH METHODOLOGY

The research methodology for Scalar Market Research’s antibody market report utilizes a combination of top-down and bottom-up research formats. Our primary focus on continuous market tracking, rigorous fact-checking, data-triangulation, and multiple layers of quality control ensures high-quality data that can be leveraged for actionable research insights.

To know about the assumptions considered for the study, Download PDF Sample.

KEY PREMIUM INSIGHTS:

  • Growing burden of chronic illnesses is expected to fuel the growth of the antibodies market.
  • Increasing awareness towards better treatment options is anticipated to increase the demand for the global antibodies market.
  • However, the stringent regulatory norms are likely to restrain the market growth.
  • Moreover, the resistance caused by some antibodies is also restricting the growth of the antibodies market.

 KEY TARGET AUDIENCE

  • Antibodies Manufacturing Companies
  • Suppliers and Distributors of Antibodies
  • Hospitals and Diagnostic Centers
  • Ambulatory Surgery Centers
  • Academic Centers
  • Venture Capitalists

MARKET SEGMENTATION

This report analyzes the antibodies market by the following segments:

  • Antibodies Market, by Types
    • Monoclonal Antibodies
    • Polyclonal Antibodies
    • Antibody Drug Conjugate
  • Antibodies Market, by Disease Indications
    • Cardiovascular Diseases
    • CNS Disorders
    • Cancer
    • Autoimmune Disorders
  • Antibodies Market, by End-users
    • Hospitals
    • Long Term Care Facilities
    • Research institutes

KEY MARKET PLAYERS

Key players in the antibodies market include:

  • F. Hoffmann-La Roche Ltd.
  • Novartis AG
  • Takeda Pharmaceutical Company Limited
  • Johnson & Johnson Services, Inc.
  • Biogen Inc.
  • Amgen Inc.
  • Bristol-Myers Squibb Company
  • Sanofi
  • AbbVie Inc.
  • Eli Lilly and Company

GEOGRAPHIC COVERAGE AND ANALYSIS

This granular market research report covers the following geographic regions in great detail:

  • NORTH AMERICA
    • U.S.
    • Rest of North America
  • EUROPE
    • France
    • Germany
    • U.K.
    • Rest of Europe
  • ASIA-PACIFIC
    • China
    • India
    • Japan
    • Rest of Asia-Pacific
  • MIDDLE EAST & AFRICA
    • GCC
    • North Africa
    • South Africa
    • Rest of Middle East & Africa
  • LATIN AMERICA
    • Brazil
    • Rest of Latin America

Antibodies Market

TRENDING RELATED REPORT

Stem Cell Therapy Market, by Treatments (Allogeneic Stem Cell Therapy, Autologous Stem Cell Therapy), Applications (Oncology, Eye Diseases, Central Nervous System Diseases, Musculoskeletal Diseases, Wound & Injuries, Metabolic Disorders, Cardiovascular Disorders, Immune System Disorders), End-users (Hospitals, Ambulatory Surgical Centers) - Global Revenue, Trends, Growth, Share, Size and Forecast to 2022


  1. MARKET OVERVIEW
    1. Definitions
    2. Research Methodology
    3. Market Segmentation
  2. EXECUTIVE SUMMARY
  3. MARKET DYNAMICS
    1. Drivers
    2. Restraints
    3. Opportunities
    4. Premium Industry Trends
  4. INDUSTRY ANALYSIS
    1. Value Chain Analysis
    2. Technology Roadmap
    3. Ecosystem Analysis
      1. Vertical Analysis
  5. ANTIBODIES MARKET, BY TYPES
    1. Segment Share
    2. Types
      1. Monoclonal Antibodies
      2. Polyclonal Antibodies
      3. Antibody Drug Conjugate
  6. ANTIBODIES MARKET, BY DISEASE INDICATIONS
    1. Segment Share
    2. Disease Indications
      1. Cardiovascular Diseases
      2. CNS Disorders
      3. Cancer
      4. Autoimmune Disorders
  7. ANTIBODIES MARKET, BY END-USERS
    1. Segment Share
    2. End-users
      1. Hospitals
      2. Long Term Care Facilities
      3. Research institutes
  8. ANTIBODIES MARKET, BY REGIONS
    1. North America
      1. By Country
        1. U.S.
        2. Rest of North America
      2. By Types
      3. By Disease Indications
      4. By End-users
    2. Europe
      1. By Country
        1. France
        2. Germany
        3. U.K.
        4. Rest of Europe
      2. By Types
      3. By Disease Indications
      4. By End-users
    3. Asia-Pacific
      1. By Country
        1. China
        2. India
        3. Japan
        4. Rest of Asia-Pacific
      2. By Types
      3. By Disease Indications
      4. By End-users
    4. Middle East & Africa
      1. By Country
        1. GCC
        2. North Africa
        3. South Africa
        4. Rest of Middle East & Africa
      2. By Types
      3. By Disease Indications
      4. By End-users
    5. Latin America
      1. By Country
        1. Brazil
        2. Rest of Latin America
      2. By Types
      3. By Disease Indications
      4. By End-users
  9. COMPETITIVE LANDSCAPE
    1. Market Share Analysis
    2. Key Innovators
  10. KEY MARKET PLAYERS
    1. F. Hoffmann-La Roche Ltd.
      1. Overview
      2. Key Strategies
      3. Recent Developments
    2. Novartis AG
      1. Overview
      2. Key Strategies
      3. Recent Developments
    3. Takeda Pharmaceutical Company Limited
      1. Overview
      2. Key Strategies
      3. Recent Developments
    4. Johnson & Johnson Services, Inc.
      1. Overview
      2. Key Strategies
      3. Recent Developments
    5. Biogen Inc.
      1. Overview
      2. Key Strategies
      3. Recent Developments
    6. Amgen Inc.
      1. Overview
      2. Key Strategies
      3. Recent Developments
    7. Bristol-Myers Squibb Company
      1. Overview
      2. Key Strategies
      3. Recent Developments
    8. Sanofi
      1. Overview
      2. Key Strategies
      3. Recent Developments
    9. AbbVie Inc.
      1. Overview
      2. Key Strategies
      3. Recent Developments
    10. Eli Lilly and Company
      1. Overview
      2. Key Strategies
      3. Recent Developments
  11. SCALAR 360 DEGREE MARKET PERSPECTIVE
  12. APPENDIX
Please submit your enquiry below so our representative can get in touch with you
*
*
*
*
*
*

USA - CANADA TOLL FREE
+1-800-213-5170
EMAIL
sales@scalarmarketresearch.com

Benefits of Buying From Scalar

  • Unparalleled Expertise

    Our industry experts hold inimitable know-how across wide range of industry verticals

  • Assured Quality

    We deliver high-quality, real-time and data-driven industry insights to our clients

  • 24x7 Analyst Support

    We offer pre-purchase and post-purchase support from our industry experts

  • Privacy & Security

    All your personal information and confidential details are safe and secure with us